Ocular Proteomics Testing In Chronic Atrophy

Inclusion Criteria: * Male or female subjects aged between 50 and 89 years, inclusive * For the GA cohort: Clinical diagnosis of GA secondary to AMD or dAMD in the study eye, confirmed by fundus autofluorescence imaging and spectral-domain optical coherence tomography (SD-OCT). * For the control cohort: No clinical evidence of retinal disease in either eye. * Best-corrected visual acuity (BCVA) of ≥20/200 in the study eye, as measured by Early Treatment Diabetic Retinopathy Study (ETDRS) charts * Ability and willingness to provide written informed consent before any study-specific procedures. Exclusion Criteria: * Presence of active ocular infection or inflammation in either eye at the time of screening. * History of intraocular surgery in the study eye within the three months preceding enrollment. * Intraocular pressure (IOP) greater than 21 mmHg in the study eye at screening * Use of systemic anticoagulation therapy that cannot be safely discontinued prior to ACP. * Pregnant or nursing women. * Known hypersensitivity or contraindication to any of the medications or procedures used in the study.